Presenting: Perlion – The Next Generation of Sun Protection
Details
Perlion (http://Perlion.com) — Co-Founder Logan Chang presenting — is developing advanced sun protection technology to address gaps in current sunscreen performance.
Traditional sunscreens primarily protect against UVB and UVA II, but growing evidence shows that UVA I and HEV (blue light) also contribute to skin aging and oxidative stress. These wavelengths can pass through most sunscreens on the market today, leaving consumers unprotected. While demand is shifting toward “full-spectrum” protection, the U.S. market lacks FDA-approved active ingredients that can block these rays due to strict regulatory constraints.
Perlion is developing solutions to bridge this gap and enable next-generation sunscreen formulations that better protect skin from the full range of harmful light exposure. The goal is to empower manufacturers with improved performance without relying on new regulated active ingredients.
Our target market is sunscreen manufacturers and skincare brands in the U.S. who need enhanced, full-spectrum protection solutions and are willing to pay for differentiation, performance, and regulatory-compliant innovation.
Our competition is traditional sunscreen formulations, cosmetic add-ons, and global brands using non-U.S.-approved ingredients. Our competitive advantage is addressing UVA I and HEV protection within U.S. regulatory constraints, enabling innovation without requiring new drug approvals.
The total market size in 2024 is the global suncare market, and the total market revenue in 2024 is $15B+.
Top 3 challenges:
- Securing funding to advance development
- Achieving clarity around regulatory classification and pathway
- Developing a benchmark formulation to demonstrate value to manufacturers
Our PitchBoulder ask: We’re looking to connect with the local angel investor community and would value feedback on both our go-to-market strategy and regulatory approach—specifically how to position this opportunity to manufacturers and investors given the constraints of the U.S. sunscreen market.
